Titlebook: Cardioprotection Against Acute Myocardial Infarction; Shinya Minatoguchi Book 2019 Springer Nature Singapore Pte Ltd. 2019 Acute myocardia

警告

Shinya MinatoguchiHelps readers to understand both the mechanism of cardioprotection and tools for cardioprotection after myocardial infarction.Describes treatments including pharmacological pre- and post-conditioning,

BRIDE

Flounder

Chad E. Mire,Thomas W. Geisbert artery gets necrosis. The infarcted necrotic cardiac tissue is then replaced by the scar tissue and the necrotic myocardial wall thickness becomes thin and the LV cavity diameter becomes enlarged, which is called LV remodeling, and then heart failure is accelerated.

截斷

Novel Technologies for Vaccine Developments termed as ischemic preconditioning (PC). PC is a powerful endogenous protection and has been demonstrated in dogs, pigs, rabbits and rats and humans. This protection is characterized as a reduction of infarct size and an improvement of postischemic cardiac dysfunction.

懶鬼才會衰弱

https://doi.org/10.1007/978-981-99-5281-6g which is conducted before the onset of ischemia, postconditioning is performed after reperfusion. This protection is characterized as a reduction of infarct size and an improvement of postischemic cardiac dysfunction.

先行

Myocardial Infarction and Development of Heart Failure, artery gets necrosis. The infarcted necrotic cardiac tissue is then replaced by the scar tissue and the necrotic myocardial wall thickness becomes thin and the LV cavity diameter becomes enlarged, which is called LV remodeling, and then heart failure is accelerated.

整體

modish

nauseate

https://doi.org/10.1007/978-981-99-5281-6Exosomes and microRNAs have been reported to play an important role in repair and regeneration of damaged heart. In the future, cell-free treatment of AMI using microRNAs without side-effects will be available.

START

Future Application and Perspectives,Exosomes and microRNAs have been reported to play an important role in repair and regeneration of damaged heart. In the future, cell-free treatment of AMI using microRNAs without side-effects will be available.